Melanoma trials in Croatia

1 trial · From EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 1Taking people
  A Double-Blind, Randomized, Three-arm, Active-Controlled, Parallel-Group, Phase 1 Study Evaluating Pharmacokinetic Similarity of Three Formulations of Pembrolizumab (CT-P51, EU-approved Keytruda, and US-licensed Keytruda) as Adjuvant Therapy in Patients with Completely Resected Stage IIB, IIC, and III Melanoma

  Where

  Rijeka

  Age

  18 years and over

  People

  83 worldwide

  Run by

  Celltrion Inc.

  See details and how to join2023-510017-26-00 · EU 2023-510017-26-00